Rankings
▼
Calendar
MESO Q1 2017 Earnings — Mesoblast Limited Revenue & Financial Results | Market Cap Arena
MESO
Mesoblast Limited
$2B
Q1 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$395,000
-94.7% YoY
Gross Profit
-$3M
-734.2% margin
Operating Income
-$22M
-5541.8% margin
Net Income
-$20M
-5012.2% margin
EPS (Diluted)
$-0.37
QoQ Revenue Growth
-98.5%
Cash Flow
Operating Cash Flow
-$21M
Free Cash Flow
-$21M
Stock-Based Comp.
$847,000
Balance Sheet
Total Assets
$665M
Total Liabilities
$156M
Stockholders' Equity
$510M
Cash & Equivalents
$16M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$395,000
$8M
-94.7%
Gross Profit
-$3M
$1M
-321.4%
Operating Income
-$22M
-$14M
-51.3%
Net Income
-$20M
-$13M
-50.4%
← FY 2017
All Quarters
Q2 2017 →